Zura Bio
ZURA · NASDAQ
$4.00+$0.19 (+4.99%)TodayMarket closed ·
Prev close $3.81
Who owns ZURA
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 63.6% of ZURA’s shares.
- Athanor Capital, LP12.2%
- Montanova Capital, LLC9.9%
- Access Industries, Inc.6.9%
- VR Adviser, LLC6.8%
- Next 6 largest institutions27.8%
- All other shareholders36.4%
| Holder | Shares | % of shares |
|---|---|---|
| Athanor Capital, LP | 11.58M | 12.19% |
| Montanova Capital, LLC | 9.44M | 9.94% |
| Access Industries, Inc. | 6.55M | 6.90% |
| VR Adviser, LLC | 6.43M | 6.77% |
| Hana Immunotherapeutics LLC | 5.40M | 5.69% |
| MPM BioImpact LLC | 4.47M | 4.71% |
| J.P. Morgan Securities LLC | 4.33M | 4.56% |
| Great Point Partners, LLC | 4.22M | 4.44% |
| Sidhu (Someit) | 3.99M | 4.20% |
| Braidwell LP | 3.98M | 4.19% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| iShares Russell 2000 ETF | 1.45M | 1.53% |
| Vanguard Extended Market Index Fund | 747.72K | 0.79% |
| Fidelity Small Cap Index Fund | 639.02K | 0.67% |
| iShares Russell 2000 Growth ETF | 557.87K | 0.59% |
| Fidelity Select Biotechnology Portfolio | 509.66K | 0.54% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of ZURA in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Nirula Ajay | Award | 51.00K | — |
| Thiara Parvinder | Award | 51.00K | — |
| Schoch Steven J | Award | 51.00K | — |
| Eisner Mark | Award | 51.00K | — |
| Becker Daniel J. | Award | 51.00K | — |
| Jarrett Jennifer | Award | 51.00K | — |
| Munshi Amit | Award | 51.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 9.37M
- Days to cover
- 4.78
- % of shares outstanding
- 9.86%
- Average daily volume
- 1.96M
- Change since last report
- +0.3%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.